Posttraumatic stress disorder (PTSD) is the third most common psychiatric diagnosis among Veterans seen in the Veterans Health Administration (VHA). PTSD can be debilitating, leading to a decline in quality of life and causing significant medical, mental health, interpersonal, and social impairment.
First-line treatments for PTSD include psychotherapy and pharmacotherapy, or a combination of the two. However, many patients do not respond to these therapies. Stellate ganglion blocks (SGB)
, also called cervical sympathetic blocks, are emerging as an alternative for individuals with PTSD who have not fully responded to conventional therapies.